Infinimmune Raises $12 Million In Seed Funding To Pioneer Novel Approach To Antibody Drug Discovery And Development
Amount Raised
$12 Million
Round Type
Seed
AlamedaBiotechnologyHealth CareTherapeuticsInvestors
Description
Infinimmune, a biotechnology company pioneering new methods for antibody drug discovery and development, today announced that it has closed a $12 million seed round led by Playground Global, with participation from Pear VC, Civilization Ventures, Axial VC, Ron Alfa, Jacob Becraft, Paul Conley, and Joshua Meier.
Quick answer
Infinimmune raised $12 Million in a Seed round, dated December 6, 2022. Investors: Axial VC, Civilization Ventures and Pear VC. Infinimmune is based in Alameda, California, United States.
- How much did Infinimmune raise?
- Infinimmune raised $12 Million in a Seed round on December 6, 2022.
- Who invested in Infinimmune?
- Axial VC, Civilization Ventures and Pear VC are named as investors in this round.
- What does Infinimmune do?
- Infinimmune is a biotechnology company pioneering a novel approach to antibody drug discovery and development.
- Where is Infinimmune based and how big is it?
- Infinimmune is based in Alameda, California, United States. Fundz records about 15 employees.
- Who are the decision-makers at Infinimmune?
- Fundz holds 1 contact at Infinimmune, including the Co-Founder and CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Infinimmune that raised within 45 days of this round, from Fundz verified event records.
- ADARx Pharmaceuticals, Inc. raised $46M (Funding Round) on January 20, 2023.
- Repare Therapeutics raised $1.5M (Seed) on January 19, 2023.
- Diamante Srl raised an undisclosed amount (Seed) on January 17, 2023.
- MPC Therapeutics raised an undisclosed amount (Seed) on January 11, 2023.
- Liquidia raised an undisclosed amount (Debt Financing) on January 9, 2023.
- Inotrem raised an undisclosed amount (Funding Round) on January 9, 2023.
Who to call at Infinimmune, and when
A new round usually means Infinimmune is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Infinimmune raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Infinimmune, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Infinimmune. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Infinimmune raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Infinimmune raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.